Autopsy report · NCT01121120
Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 10 years 6 months before it stopped.
- 75 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Tarix Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Lymphoma, Non-Hodgkin; Hodgkin Disease; Multiple Myeloma
- Interventions
- TXA127; Placebo
- Participants
- 75
- Sites
- 10
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.